The American Chemical Society's ACS ProSpectives conference series provides industry medicinal chemists and life scientists with focused conferences that explore the discovery, development and production of pharmaceuticals and therapeutics. http://listmailer1.acs.org/t/8044/4760961/4013/0/

Please take at look at first three conferences for 2007:

Crystallization Process Development: Case Studies & Research
http://listmailer1.acs.org/t/8044/4760961/4014/0/
Feb. 25 - 27, 2007 in Cambridge at the Royal Sonesta Boston

This 2-day conference will be split into one day on PAT and process development and one day on solid forms. The conference will feature:
· 10 top academics presenting their latest research on crystal process development and scale-up, ionic liquids in crystallization, melt crystallization, nucleation, co-crystals, and the theory and application of polymorphism to practical pharma problems
· Speakers from Novartis, Eli Lilly, Astra Zeneca, ETH Zurich, SSCI and Solvias AG will all present practical applications of this science to real pharmaceutical systems

Discovery and Selection of Successful Drug Candidates
http://listmailer1.acs.org/t/8044/4760961/4015/0/
April 30 - May 2, 2007 in Boston at the Hotel Intercontinental

This meeting will consist of half-day sessions on the following drivers for the successful identification of drug candidates:
* Target and Lead Discovery
* Structure-Based Design
* Selectivity (Enzyme, GPCR, hERG, etc)
* ADME/Tox
* VP Case Studies on Compounds That Made it to the Clinic ; How They Did It, What They Would Do Differently Today
Roughly 20 case studies will be presented by group leader-to-VP level speakers who work in big pharma and biotech.

Process Chemistry in the Pharmaceutical Industry
http://listmailer1.acs.org/t/8044/4760961/4016/0/
Sept. 30 - Oct. 3, 2007 in Cambridge at the Royal Sonesta Boston

·Keynotes by Barry Trost of Stanford and Mauricio Futran of BMS
·A Regulatory Roundtable led by John Simmons, recently retired from the FDA, who will cover how to plan for the changes at FDA-CDER, Quality By Design and getting an API from phase I through pahse III.
·Senior level industry professionals from Merck, Abbott, Pfizer, Boehringer-Ingelheim, and GSK will present case studies from their work
·Leading academics Eric Jacobsen of Harvard, Tim Jamison of MIT, Dave MacMillan of Princeton and Brian Stoltz of Cal Tech will also present their research

Additional conferences scheduled for 2007:

·PK/PD for Medicinal Chemists
October 28 - 30 in Philadelphia at the Westin Philadelphia
·Advances in Structure-Based Drug Discovery http://listmailer1.acs.org/t/8044/4760961/4017/0/
Sept. 9 - 11, 2007 in San Francisco at the Hyatt Regency Airport
·Successful Biologics: Formulation to Manufacturing
http://listmailer1.acs.org/t/8044/4760961/4018/0/
Nov. 4 - 6, 2007 in Philadelphia at the Westin Philadelphia

Go to www.acsprospectives.com to obtain the most complete, up-to-date information available on topics, speakers, and venue for all our 2007 conferences.